3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Glioblastoma
11
Squamous Cell Carcinoma of Head and Neck
10
Sarcoma
10
Rectal Neoplasms
8
Esophageal Neoplasms
8
Stomach Neoplasms
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Brain Neoplasms
5
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Hypopharyngeal Neoplasms
4
Head and Neck Neoplasms
4
Glioma
4
Colonic Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Astrocytoma
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Interventions
pertuzumab
1
Validation Studies as Topic
1
Trastuzumab
1
Tape Recording
1
Surgical Procedures, Operative
1
Radiotherapy
1
Opdualag
1
Nivolumab
1
Injections, Subcutaneous
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Preference
×
Surgical Procedures, Operative
×
1 year
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts